ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Biotechnology

ADC Therapeutics

ADC Therapeutics' headquarters in Lausanne, Switzerland

Ameet Mallik

Patrick van Berkel

Kristen Harrington-Smith

Mohamed Zaki

David Ege

Jay Feingold

Kimberly Pope

Will Dolan

Jose Carmona

Jada Baijnath

Niall M.

Peter Graham

Bob Azelby

Ron Squarer

Stephen Evans-Freke

Viviane Monges

Peter Hug

Thomas Pfisterer

Tyrell J. Rivers

Victor Sandor

Jean-Pierre Bizzari

The Leadership Team at ADC Therapeutics is responsible for setting the strategic direction and overall vision of the company as it advances its innovative antibody drug conjugates for oncology. Comprising executives from key areas such as commercial operations, scientific research, regulatory affairs, and finance, this team collaborates to drive product development, ensure compliance, optimize operational efficiency, and foster a strong corporate culture while navigating the unique challenges of the biotechnology landscape.

Leadership Team

This department focuses on providing specialized care and support in hematology, addressing conditions related to blood and blood disorders.

Hematology Services

The Clinical Operations and Development team at ADC Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials to evaluate the safety and efficacy of novel antibody drug conjugates. This team collaborates with cross-functional partners to ensure regulatory compliance, optimize trial design, and facilitate timely data collection and analysis, ultimately aiming to enhance the development pipeline and support the commercialization of innovative oncology therapies.

Clinical Operations and Development

This department focuses on managing and nurturing key client relationships to drive business growth and enhance customer satisfaction.

Strategic Accounts

The Finance and Accounting team at ADC Therapeutics is responsible for managing the company’s financial health and compliance, ensuring accurate reporting and strategic financial planning. This team oversees budgeting, forecasting, and financial analysis to support the development and commercialization of innovative cancer therapies. Additionally, they handle technical accounting, external reporting, and finance systems management to align financial operations with corporate objectives.

Finance and Accounting

This department oversees regulatory strategies and clinical trial management to ensure compliance and successful drug development.

ADC Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Hematology Services

Clinical Operations and Development

Strategic Accounts

Finance and Accounting

Regulatory Affairs and Clinical Development

Offices

ADC Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Hematology Services

Clinical Operations and Development

Strategic Accounts

Finance and Accounting

Regulatory Affairs and Clinical Development

Offices

Related companies